The probiotics are being used as ecofriendly and bioremediation tools for developing sustainability to aquaculture. The present study was conducted to explore the practical capability of using dietary lactic acid bacteria (Pediococcus acidilactici) probiotics and see how its dose variation affected the water quality, growth performance, survival rate, body composition, blood biochemical parameters, and intestinal histology of European sea bass (Dicentrarchus labrax L.). A total of 120 fingerlings with an initial weight of g were divided into four groups, each with three replicates. The feeding experiment lasted for 60 days. In addition to the control (without probiotics) (T0), fish were fed diets containing (T1) 2.0, (T2) 2.5, and (T3) 3.0 g of probiotics per kg of diet twice a day. When compared to the control, sea bass fed probiotic-supplemented diets had significantly higher growth parameters, fish body “crude lipid,” and villi height ( , , and ). The P. acidilactici probiotic treatments improved survival rate, feed conversion ratio, body composition, and blood biochemical markers, but not statistically significant ( ). Also, in regard to water quality, P. acidilactici drastically reduced ammonia and pH levels. In this experiment, fish fed with a dosage of 3.0 g of this commercial probiotic per kg of probiotics performed better. The study found that including probiotics in the diets of European sea bass improved growth, body composition, survival rate, blood biochemical markers, intestinal histology, and some water quality parameters.

In recent decades, probiotics have become an acceptable aquaculture strategy for shrimp growth promotion and immune modulation. This study aimed to evaluate the effect of Bacillus velezensis on Litopenaeus vannamei following a 60-day trial. L. vannamei (3 ± 0.4 g) were distributed into four groups with three replicates per group and fed an isonitrogenous diet supplemented with B. velezensis at 0, 1 × 10⁷, 1 × 10⁸, and 1 × 10⁹ CFU/g, which were defined as the control, G1, G2, and G3 groups, respectively. B. velezensis significantly improved the growth, survival rate, and proximate body composition of L. vannamei (P < 0.05). All groups fed the B. velezensis diet showed significant increases in digestive enzymes (lipase, amylase, and protease), superoxide dismutase (SOD; G3), catalase (CAT; G3, G2, and G1), lysozyme activity (G3 and G2), immunoglobulin M (IgM), bactericidal activity BA%, alkaline phosphatase (AKP), and acid phosphatase (ACP) compared with the control group (P < 0.05). Malondialdehyde (MDA), triglycerides, cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) levels were significantly decreased in all groups fed B. velezensis diet compared with the control group (P < 0.05). The expression levels of SOD (G3), LZM, and serine proteinase genes were significantly higher in L. vannamei fed diets containing B. velezensis than in the control group (P < 0.05). This is the first study to address the effects of B. velezensis on the expression of the LZM and serine proteinase genes in L. vannamei. L. vannamei fed diet containing B. velezensis had more B and R cells in its hepatopancreas than did the control group. In conclusion, B. velezensis is a promising probiotic that can be safely added to the diet of L. vannamei with 1 × 10⁹ CFU/g. Its application had a positive influence on the health status, survival rate, nutritional value, and immunity of L. vannamei.